- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UP-32-0004072

About Vision Parenteral Private Limited
Data last updated:
Vision Parenteral Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 June 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2011PTC045130. Its GSTIN is 09AAECV0414G1ZL (Uttar Pradesh).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹5.71 Cr. It is led by directors including Sumit Agrawal and Sandeep Agrawal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Gandhi Ashram Gali Opp. Garg Hospital 1st Floor Umarajee Building Golghar, Gorakhpur, Uttar Pradesh, India – 273001.
As per the financials filed for FY 2025, the company reported a revenue of ₹64.47 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹3.69 Cr (net margin 5.7%) and EBITDA of ₹10.18 Cr (EBITDA margin 15.8%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 33% over five years.
The company has about 83 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vision Parenteral. As per MCA filings, the company has open charges of ₹26.43 Cr on record. The company has 5 deals on record (2 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.98 Cr; the latest was in October 2022. Its 6 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 3 smaller; the largest is Valary Lab Private Limited with revenue of ₹65.12 Cr.
Vision Parenteral Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-32-0004072). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website visionparenteral.com.
Company details
Recognitions & Rankings of Vision Parenteral
Contact details
Vision Parenteral Private Limited's registered office is in Gorakhpur, Uttar Pradesh. Its website is visionparenteral.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressGandhi Ashram Gali Opp. Garg Hospital 1st Floor Umarajee Building Golghar, Gorakhpur, Uttar Pradesh, India – 273001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vision Parenteral Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Vision Parenteral operates one associated brand: Vision Parenteral. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures intravenous fluids and hospital consumables with state-of-the-art FFS and BFS technologies. | visionparenteral.com |
Business activity
The main business activity of Vision Parenteral is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vision Parenteral Private Limited, buy the company report.
Financials of Vision Parenteral Private Limited
FY 2024 filings availableVision Parenteral Private Limited reported revenue of ₹64.47 Cr (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 8% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.69 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.8% | ||||
| Net Profit Margin | 5.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vision Parenteral Private Limited, buy the company report.
Board of directors of Vision Parenteral Private Limited
Vision Parenteral has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sumit Agrawal | Director | 29 May 2015 | 11 Years 5 Months | Current |
| Sandeep Agrawal Also directs: Vision Surgimed Private Limited | Director | 03 Jun 2011 | 15 Years 5 Months | Current |
| Subodh Agrawal | Director | 03 Jun 2011 | 15 Years 5 Months | Current |
Peer comparison
Vision Parenteral Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valary Lab Private Limited | ₹65.12 Cr (FY 2025) | 0.0% | Hyderabad, Telangana, India | |||
| Biovivid Labs Pharmaceuticals Private Limited | ₹64.61 Cr (FY 2025) | 121.0% | Delhi, India | |||
| Asiatic Drugs and Pharmaceuticals Private Limited | ₹64.49 Cr (FY 2025) | 25.0% | New Delhi, Delhi, India | |||
| Vision Parenteral Private Limitedthis company | ₹64.47 Cr (FY 2025) | ₹3.69 Cr | 5.7% | 8.0% | 83 | Gorakhpur, Uttar Pradesh, India |
| Astal Laboratories Limited | ₹64.36 Cr (FY 2025) | 172.0% | Noida, Uttar Pradesh, India | |||
| Arbro Pharmaceuticals Private Limited | ₹64.16 Cr (FY 2025) | -9.0% | Delhi, India | |||
| Kilitch Healthcare India Limited | ₹63.63 Cr (FY 2024) | 7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Vision Parenteral Private Limited, buy the company report.
Auditor
Vision Parenteral Private Limited is audited by AGRAWAL SARAF & CO. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGRAWAL SARAF & CO. | FY 2021 | 007470N |
Shareholding
The shareholding of Vision Parenteral Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vision Parenteral Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2025 | 101073853 | Sidbi | ₹1 Cr | Open | |
| 23 Oct 2024 | 100998786 | Sidbi | ₹97.37 Lakh | Open | |
| 16 Feb 2024 | 100884637 | Sidbi | ₹4.72 Cr | Open | |
| 19 May 2023 | 100730452 | Sidbi | ₹61.36 Lakh | Open | |
| 24 Mar 2023 | 100693006 | Sidbi | ₹1.57 Cr | Open |
To see the full charge records of Vision Parenteral Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Vision Parenteral Private Limited has 5 deals on record (2 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.98 Cr; the latest was in October 2022.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2022 | Rights issue | ₹1 Cr | Investors: Sandeep Agrawal HUF, 3 individuals |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: Sandeep Agrawal HUF Seller: an individual |
| Dec 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| May 2014 | Funding round | ₹3.26 Cr | Investors: Sandeep Agrawal HUF, Subodh Agrawal Huf, 2 individuals |
| Nov 2013 | Funding round | ₹1.72 Cr | Investors: Sandeep Agrawal HUF, 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vision Parenteral Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Vision Parenteral Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Vision Parenteral Private Limited has a workforce of 83 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 83 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 |
To see the full employee and EPFO history of Vision Parenteral Private Limited, buy the company report.
GST
Vision Parenteral has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAECV0414G1ZL | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vision Parenteral Private Limited, buy the company report.
Recent activity
Vision Parenteral Private Limited has 4 board changes on record since 2011: 3 appointments and 1 cessation. The latest: Sumit Agrawal ceased to be Additional Director on 30 Sep 2016.
4 earlier events are in the company report.
Frequently asked questions
Vision Parenteral is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 June 2011 (15+ years old) and is registered under CIN U24233UP2011PTC045130.
Vision Parenteral has 3 current directors:
- Sumit Agrawal - Director
- Sandeep Agrawal - Director
- Subodh Agrawal - Director
The latest financial statements of Vision Parenteral on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Vision Parenteral is 09AAECV0414G1ZL, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Vision Parenteral is U24233UP2011PTC045130. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vision Parenteral was incorporated on 03 June 2011, making it 15+ years old. It is registered with the Registrar of Companies, Kanpur.
Vision Parenteral has 5 deals on record (2 secondary share transfers, 2 funding rounds, 1 rights issue), with disclosed funding of ₹4.98 Cr; the latest was in October 2022.
The peers of Vision Parenteral by revenue are Valary Lab Private Limited, Biovivid Labs Pharmaceuticals Private Limited, Asiatic Drugs and Pharmaceuticals Private Limited, Astal Laboratories Limited, Arbro Pharmaceuticals Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sumit Agrawal ceased to be Additional Director on 30 Sep 2016. Sumit Agrawal was appointed as Director on 29 May 2015. Sandeep Agrawal was appointed as Director on 03 Jun 2011. Vision Parenteral has 4 board changes on record in total.
Yes, Vision Parenteral is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-32-0004072).
Vision Parenteral can be reached through the website visionparenteral.com. Its registered office is in Gorakhpur, Uttar Pradesh, India.

